In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma
By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma
By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
,
In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology
…great potential in combination with nivolumab and to be most effective as the first treatment of metastatic melanoma. This study…
,
AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center
…for melanoma while improving the lives of those it affects. AIM’s global research initiatives include The International Melanoma Tissue Bank…
,
,
Spinning For Melanoma
…accelerate the quest for the cure. Val’s drive came from her daughter Charlie’s death from melanoma at 26 years old.…
,
,
In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma
…forms of immunotherapy. Additionally, because melanoma is so resistant to chemotherapy and radiation, the relative benefits of immunotherapy are greater…
,
,
AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University
…The International Melanoma Tissue Bank Consortium, The Melanoma International Collaboration for Adaptive Trials, and the International Melanoma Working Group. AIM…
,
,
Interview with Allison Betof Warner, MD, PhD: TIL Therapy
…types of melanoma? Acral, mucosal, cutaneous, and melanoma of unknown primary origin are approved. These types of melanoma were included…
,
Tonia Sylvester: Why She Fights
…the medical team noticed a cluster of tiny little brown spots on her lower leg, which is referred to as…
,
In Plain English: Options for Stage III Melanoma
…III melanoma is considered high-risk—meaning it has a high likelihood of recurring or spreading. In fact, patients with Stage III…
,
In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses
By Kim Margolin, M.D. Using the patient’s own immune system to combat melanoma is a powerful tool for patients…
,
Recent Posts
Apr. 02, 2026
Uveal Melanoma Webinar: Part II — Navigating Treatment in the Metastatic Setting
Mar. 26, 2026
Wade Watson, Stage III Melanoma Survivor
Mar. 03, 2026
Cancer is More Than a Diagnosis: Mind, Meaning, and Healing
Feb. 19, 2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
Feb. 05, 2026